C
DNLI icon

Covestor’s Denali Therapeutics DNLI Stock Holding History

Covestor’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
347
+25
+8% +$514 0.01% 1654
2026
Q1 		$6K Sell
322
-257
-44% -$5.11K ﹤0.01% 1721
2025
Q4 		$10K Hold
579
– – 0.01% 1565
2025
Q3 		$8K Sell
579
-1
-0.2% -$14 ﹤0.01% 1720
2025
Q2 		$8K Sell
580
-1
-0.2% -$14 ﹤0.01% 1670
2025
Q1 		$8K Buy
581
+2
+0.3% +$38 0.01% 1611
2024
Q4 		$12K Buy
579
+1
+0.2% +$26 0.01% 1420
2024
Q3 		$17K Hold
578
– – 0.01% 1267
2024
Q2 		$13K Sell
578
-10,166
-95% -$195K 0.01% 1364
2024
Q1 		$220K Buy
10,744
+3,589
+50% +$67.5K 0.14% 135
2023
Q4 		$154K Buy
7,155
+6,865
+2,367% +$136K 0.11% 249
2023
Q3 		$6K Sell
290
-1
-0.3% -$25 ﹤0.01% 1670
2023
Q2 		$9K Sell
291
-2
-0.7% -$56 0.01% 1494
2023
Q1 		$7K Buy
293
+91
+45% +$2.5K 0.01% 1466
2022
Q4 		$6K Sell
202
-1
-0.5% -$30 ﹤0.01% 1508
2022
Q3 		$6K Buy
203
+190
+1,462% +$6.18K 0.01% 1434
2022
Q2 		$0 Sell
13
-245
-95% -$6.42K ﹤0.01% 2007
2022
Q1 		$8K Buy
258
+103
+66% +$3.54K 0.01% 1379
2021
Q4 		$7K Buy
+155
New +$7.34K 0.01% 1144

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Covestor's DNLI Position: Q2 2026 in Review

Covestor increased its Denali Therapeutics (DNLI) stake by 7.8% in Q2 2026, buying an estimated $514 and bringing the position to 347 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #1654.

Covestor first reported a position in DNLI in Q4 2021 and has held it in 19 quarters since. The position peaked at $220K in Q1 2024. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Covestor held 347 shares of Denali Therapeutics worth $9K as of Q2 2026.
  • Covestor bought 25 Denali Therapeutics shares in Q2 2026, an estimated $514.
  • Denali Therapeutics made up 0.01% of Covestor's portfolio in Q2 2026, its #1654 holding.
  • Covestor first reported a position in Denali Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Denali Therapeutics position peaked at $220K in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.